Anthera Pharmaceuticals, Inc. (OTCPK: ANTH)
Health Care · Biotechnology · US
$0.00
+35.00% today · +13400.0% 1Y
Anthera Pharmaceuticals, Inc. (OTCPK: ANTH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.53K and employs 21 people.
Over the last twelve months the share price has gained 13400.0%, trading between 0.00 and 0.00.
Tweenvest scores Anthera Pharmaceuticals, Inc. across four factors: quality 35/100, value 53/100. Its strongest factor is value.
ANTH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.53K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.76
- Dividend yield
- —
- Beta (5Y)
- -65.78
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 26.18M
- Employees
- 21
- Next earnings
- —
About Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
- ISIN
- US03674U3005
- Founded
- 2004
- Listed since
- Mar 1, 2010
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MultiCell Technologies, Inc.OTCPK: MCET | $5.00K | $0.00 | — |
| Arno Therapeutics, Inc.OTCPK: ARNI | $4.98K | $— | — |
| Panbela Therapeutics, Inc.OTCPK: PBLA | $4.86K | $0.00 | -66.67% |
| Evelo Biosciences, Inc.OTCPK: EVLO | $3.80K | $0.00 | +100.00% |
| Todos Medical Ltd.OTCPK: TOMD.F | $3.32K | $0.00 | — |
| Rebus Holdings, Inc.OTCPK: RBSH | $3.21K | $0.00 | +9900.00% |
| Comera Life Sciences Holdings, Inc.OTCPK: CMRA | $3.07K | $— | — |
| Innoveren Scientific Inc.OTCPK: IVRN | $2.40K | $0.00 | — |
Figures last refreshed Oct 18, 2026.